OTCMKTS:EXETF Extendicare (EXETF) Stock Price, News & Analysis $10.27 +0.05 (+0.49%) As of 05/9/2025 01:52 PM Eastern Add Compare Share Share Stock Analysis Stock AnalysisAnalyst ForecastsChartDividendHeadlinesShort InterestBuy This Stock About Extendicare Stock (OTCMKTS:EXETF) 30 days 90 days 365 days Advanced Chart View Price History Chart DataSkip Price History Chart Get Extendicare alerts:Sign Up Key Stats Today's Range$10.27▼$10.2750-Day Range$8.91▼$10.5452-Week Range$5.22▼$11.00Volume305 shsAverage Volume6,189 shsMarket CapitalizationN/AP/E RatioN/ADividend Yield4.67%Price TargetN/AConsensus RatingHold Company OverviewExtendicare Inc., through its subsidiaries, provides care and services for seniors in Canada. The company offers long term care (LTC) services; and home health care services, such as nursing care, occupational, physical and speech therapy, and assistance with daily activities, as well as management, consulting, and other services to third parties. It operates through the Extendicare, ParaMed, Extendicare Assist, and SGP Purchasing Partner Network brands. The company was incorporated in 1968 and is based in Markham, Canada.Read More… Extendicare Stock Analysis - MarketRank™See Top-Rated MarketRank™ Stocks3rd Percentile Overall ScoreEXETF MarketRank™: Extendicare scored higher than 3% of companies evaluated by MarketBeat. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation. Analyst's OpinionN/AAnalyst RatingN/A Consensus RatingThere is not enough analysis data for Extendicare.Read more about Extendicare's stock forecast and price target. Earnings and Valuation0.0 / 5Proj. Earnings GrowthN/A Price to Earnings Ratio vs. the MarketThe P/E ratio of Extendicare is -39.58, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of Extendicare is -39.58, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings. Short Interest1.0 / 5Short Interest LevelBearish Percentage of Shares ShortedShort Interest Ratio / Days to CoverExtendicare has a short interest ratio ("days to cover") of 175.6, which indicates bearish sentiment.Change versus previous monthShort interest in Extendicare has recently decreased by 0.17%, indicating that investor sentiment is improving. Dividend1.7 / 5Dividend StrengthWeak Dividend LeadershipExtendicare is a leading dividend payer. It pays a dividend yield of 8.00%, putting its dividend yield in the top 25% of dividend-paying stocks.Dividend GrowthExtendicare does not have a long track record of dividend growth.Read more about Extendicare's dividend. Sustainability and ESGN/AEnvironmental ScoreN/A Percentage of Shares ShortedShort Interest Ratio / Days to CoverExtendicare has a short interest ratio ("days to cover") of 175.6, which indicates bearish sentiment.Change versus previous monthShort interest in Extendicare has recently decreased by 0.17%, indicating that investor sentiment is improving. News and Social Media1.9 / 5News Sentiment0.45 News SentimentExtendicare has a news sentiment score of 0.45. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.85 average news sentiment score of Medical companies.News Coverage This WeekMarketBeat has tracked 5 news articles for Extendicare this week, compared to 0 articles on an average week. Company Ownership0.0 / 5Insider TradingN/A Insider Buying vs. Insider SellingIn the past three months, Extendicare insiders have not sold or bought any company stock.Percentage Held by InstitutionsOnly 9.44% of the stock of Extendicare is held by institutions.Read more about Extendicare's insider trading history. Receive EXETF Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Extendicare and its competitors with MarketBeat's FREE daily newsletter. Email Address EXETF Stock News HeadlinesExtendicare Inc. Earnings Call Highlights Robust GrowthMay 12 at 9:46 PM | tipranks.comExtendicare Inc. (EXETF) Q1 2025 Earnings Call TranscriptMay 10 at 5:03 AM | seekingalpha.comWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon bring Elon Musk's DOGE operation to its final, dramatic conclusion - with huge consequences for millions of investors. So if you have any money in the market... you're almost out of time to prepare. This plan has already been put in place... and can operate even if Elon's long gone from Washington. May 13, 2025 | Altimetry (Ad)Extendicare Inc (EXETF) Q1 2025 Earnings Call Highlights: Strong Growth and Strategic Moves ...May 8, 2025 | finance.yahoo.comExtendicare Inc: Extendicare Announces 2025 First Quarter ResultsMay 7, 2025 | finanznachrichten.deExtendicare Announces 2025 First Quarter ResultsMay 6, 2025 | globenewswire.comStocks in play: Extendicare Inc.May 1, 2025 | ca.finance.yahoo.comExtendicare Announces Agreement to Acquire Closing the Gap Healthcare GroupMay 1, 2025 | theglobeandmail.comSee More Headlines EXETF Stock Analysis - Frequently Asked Questions How have EXETF shares performed this year? Extendicare's stock was trading at $7.27 at the start of the year. Since then, EXETF shares have increased by 41.3% and is now trading at $10.27. View the best growth stocks for 2025 here. How do I buy shares of Extendicare? Shares of EXETF stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Company Calendar Ex-Dividend for 4/15 Dividend3/31/2025Record date for 4/15 Dividend4/01/2025Dividend Payable4/15/2025Ex-Dividend for 5/15 Dividend4/30/2025Record date for 5/15 Dividend5/01/2025Today5/13/2025Dividend Payable5/15/2025Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeOTCMKTS SectorMedical Industry Medical Care Facilities Sub-IndustryTrading Current SymbolOTCMKTS:EXETF CIKN/A Webwww.extendicare.com Phone(905) 470-4000FaxN/AEmployees23,000Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AMiscellaneous Outstanding SharesN/AFree FloatN/AMarket CapN/A OptionableNot Optionable BetaN/A The Next 7 Blockbuster Stocks for Growth InvestorsWondering what the next stocks will be that hit it big, with solid fundamentals? Enter your email address to see which stocks MarketBeat analysts could become the next blockbuster growth stocks.Get This Free Report This page (OTCMKTS:EXETF) was last updated on 5/13/2025 by MarketBeat.com Staff From Our PartnersTrump wipes out trillions overnight…Is there anybody more powerful than Donald Trump right now? In a single tariff announcement, he wiped out n...Porter & Company | SponsoredWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | SponsoredVirtually Limitless Energy?A radical energy breakthrough could change everything. Scientists at MIT and a stealth startup may have discov...Stansberry Research | Sponsored3..2..1.. AI 2.0 ignition (don’t sleep on this)I just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | SponsoredGold Alert: The Truth About Fort Knox Is ComingOwning physical gold isn’t the best way to profit. I’ve found a better way to invest in gold—one that’s alr...Golden Portfolio | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowMy friends Joel and Adam have a simple motto: "For us, it's always a bull market." That’s because their 92%...Crypto Swap Profits | SponsoredWhy Elon put $51 million into thisWhy Elon Musk Just Invested $51 Million Into Brand New “Miracle Metal” Developed by MIT ScientistsTrue Market Insiders | SponsoredThe Last Time This Happened, Americans Lost BillionsWall Street leaders just held a secret meeting in Las Vegas. What they discussed mirrors 2006 — and the warnin...Banyan Hill Publishing | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Extendicare Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Extendicare With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.